Home Featured Page 64

Featured

Latest

Breaking: FDA Awards Priority Review Vouchers to Otsuka, Compass, and Usona

Erica Rex: Seeing What Is There, Trauma, Integration, and the Limits of Psychedelic Therapy

Why Ketamine Is Changing Psychiatry

Trump’s Psychedelics Executive Order: Reactions From Across the Field and Beyond

Pinco Güncel Giriş Şifrənizi Yeniləmənin Əhəmiyyəti

Updates from MAPS: Current Initiatives, Psychedelic Science 2024, and Music as...

Developing Esketamine (Spravato) and Lessons for Psychedelic Drug Developers with Jaskaran...

Navigating Psychedelics for Clinicians and Wellness Practitioners: LIVE

What is Holding Space: Guiding Psychedelic Journeys and Creating Ideal Set...

Preserving Psychedelic Legacies: Shulgin Farm and the Shulgin Archive Project

Natural Medicine Advisory Bulletin 10.1: Legislative Update

MindMed’s ‘Total Elimination’ of Psychotherapy in LSD Study Stokes Debate Around...

Women and Psychedelics, Microdosing, and the Challenges of Psychedelic Parenthood

Natural Medicine Advisory Bulletin 10: March 2024

Breaking: FDA Awards Priority Review Vouchers to Otsuka, Compass, and Usona

Erica Rex: Seeing What Is There, Trauma, Integration, and the Limits...

Why Ketamine Is Changing Psychiatry

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Breaking: FDA Awards Priority Review Vouchers to Otsuka, Compass, and Usona

Erica Rex: Seeing What Is There, Trauma, Integration, and the Limits of Psychedelic Therapy

Why Ketamine Is Changing Psychiatry

Trump’s Psychedelics Executive Order: Reactions From Across the Field and Beyond

Pinco Güncel Giriş Şifrənizi Yeniləmənin Əhəmiyyəti

Updates from MAPS: Current Initiatives, Psychedelic Science 2024, and Music as...

Developing Esketamine (Spravato) and Lessons for Psychedelic Drug Developers with Jaskaran...

Navigating Psychedelics for Clinicians and Wellness Practitioners: LIVE

What is Holding Space: Guiding Psychedelic Journeys and Creating Ideal Set...

Preserving Psychedelic Legacies: Shulgin Farm and the Shulgin Archive Project

Natural Medicine Advisory Bulletin 10.1: Legislative Update

MindMed’s ‘Total Elimination’ of Psychotherapy in LSD Study Stokes Debate Around...

Women and Psychedelics, Microdosing, and the Challenges of Psychedelic Parenthood

Natural Medicine Advisory Bulletin 10: March 2024

Is Cannabis a Psychedelic?

EDITOR PICKS

Breaking: FDA Awards Priority Review Vouchers to Otsuka, Compass, and Usona

Erica Rex: Seeing What Is There, Trauma, Integration, and the Limits...

Why Ketamine Is Changing Psychiatry

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY